AP 102Alternative Names: AP102; Somatostatin analogue - Amryt Pharma
Latest Information Update: 14 Dec 2016
At a glance
- Originator Amryt Pharma
- Class Pancreatic hormones; Peptides; Pituitary hormone release inhibiting hormones
- Mechanism of Action Corticotropin-releasing factor antagonists; Growth factor receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Acromegaly; Cushing syndrome
Most Recent Events
- 05 Dec 2016 Preclinical trials in Cushing's syndrome and Acromegaly in UK